Australia's most trusted
source of pharma news
Thursday, 07 May 2026
Posted 7 May 2026 PM
Novo Nordisk has been named one of TIME’s Top 100 Most Influential Companies of 2026. The Danish giant was the only Big Pharma to make it onto the list.
Novo got the TIME tick of approval for developing the first oral GLP-1 drug for weight loss to be approved by the US FDA. Its daily pill version of Wegovy received FDA approval in December last year.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.